Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Cowboys, RB Ezekiel Elliott reuniting after deal: AP source !

Cowboys, RB Ezekiel Elliott reuniting after deal: AP source

Time:2024-05-22 10:17:51 source:World Weave news portal

DALLAS (AP) — The Dallas Cowboys are reuniting with running back Ezekiel Elliott after agreeing to terms on a contract with the former two-time rushing champion, a person with knowledge of the deal said Monday.

Elliott returns to the Cowboys a year after they let him go in a cost-cutting move. The person spoke to The Associated Press on condition of anonymity because the agreement was pending a physical.

The Cowboys acknowledged during the draft last weekend that they had recently met with Elliott and his representatives.

Dallas didn’t draft a running back after moving from its starter each of the past two seasons, and owner and general manager Jerry Jones said he thought Elliott was still a starting-caliber back.

Elliott rejoins a team that includes Rico Dowdle, Elliott’s teammate from 2020-22, and second-year players Deuce Vaughn and Hunter Luepke. Dallas also added journeyman Royce Freeman this offseason.

Related information
  • Mariachis. A flame
  • Why the Algarve has been named the top destination for a bargain break in Europe
  • National trying to wriggle out of promises with talk of 'fragile' economy
  • Next generation will pay the price for critical transport projects, councillor warns
  • Closing prices for crude oil, gold and other commodities
  • The $1m PR and lobbying campaign to overturn livestock export ban
  • A silenced merry
  • Telling the story of Taiwan beyond the cross
Recommended content
  • Election 2024: Nikki Haley faces a key decision on whether or not to endorse Trump
  • Target launches new paid membership program in a bid to drive increased sales
  • Cancer experts urge Pharmac to fast
  • Your guide to a year in Greece: Time your trip to get the best of the country's historic sites
  • Rajasthan Royals launch ANOTHER bid to invest in cash
  • Cancer experts urge Pharmac to fast